Punitive Damages: FDA-Approved Drugs: HB 1093 (1991).
Expands 1990’s prohibition against seeking punitive damages in cases in
Expands 1990’s prohibition against seeking punitive damages in cases in which FDA approved drugs are administered by a physician, to include medically prescribed drugs or products used on an experimental basis (when such experimental use has not received specific FDA approval) and when the patient has given informed consent.
Latest News
View all news
Support for Johnson & Johnson’s Appeal In Massive Oklahoma Opioid Judgment
ATRA files amicus brief in support of Johnson & Johnson’s decision to appeal a 2019 $465 million judgment against the company, warning against the state attorney general’s expansive use of public nuisance law.
Lawsuit Abuse Awareness Week: This affects all of us
ATRA President Tiger Joyce spoke with Juliette Farley of the Southern California Record about Lawsuit Abuse Awareness Week and business interruption lawsuits.
First Ga. COVID-19 Business Interruption Ruling
ATRA President Tiger Joyce spoke with Rosie Manins of the Law360 about business interruption lawsuits in the wake of COVID-19.
Transparency A Priority For Montana AG Candidate
ATRA reports Montana attorney general candidate Austin Knudsen signed its AG Transparency Code pledge.
SCOTUS to Rule on Jurisdiction After State Courts Ignore Guidance
ATRA urges SCOTUS to push back the on overly expansive approaches to jurisdiction shown by courts in Minnesota and Montana.
North Carolina AG Candidates Fail To Embrace Government Transparency
ATRA reports North Carolina attorney general candidates’ inaction on transparency code pledge.